Hawkins stock
HWKNNASDAQHawkins, Inc., Basic MaterialsISIN US4202611095
68Score 68 out of 100, Neutral
Price and trend
59 / 100
Price history
+13% in one yearThe chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Above the 200-day line: the price is 5.0% above it.
Since August 2026 the 50-day line has been below the 200-day line; the trend has turned down.
Overheated: the price has risen very quickly lately (RSI 72).
The price is 12% below its 52-week high. Largest decline in 20 years: 49% (January 2017 to March 2020).
Chart figures for advanced users
- SMA 50$134.56
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$143.21
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)72
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDbelow the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$117.67
- The lowest closing price of the last twelve months.
- Resistance$171.68
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Hawkins, Inc. belongs to the Chemicals (Specialty) industry (United States) and, with a market value of $3.13B, is number 76 of 106 companies in its industry on MEQIRI.
- In fiscal 2026 it reported revenue of $1.08B (up 11.2% year on year) and earnings of $81.55M (down 3.3%).
- For fiscal 2027, analysts expect on average revenue of $1.19B (up 9.6%) and adjusted earnings per share of $4.17 (up 5.8%).
Show more
- MEQIRI Score 68 out of 100 (Neutral): rank 99 of 461 in Basic Materials, median 57.
- The P/E is 36.4 (Chemicals (Specialty) median 24.4, own median of recent years 17.9).
- Our model puts fair value at $95.36, with the price 58% above it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Reliable dividendNo dividend cut for 25 years.Capital allocation 68
- Growing faster than its industryRevenue up 12.7% a year since 2021, Chemicals (Specialty) median 6%.Growth 84
- Earnings per share growingUp 15% a year since 2021.Growth 84
Weaknesses
- Above fair valuePrice 58% above the fair value of $95.36.Valuation 27
- Richly valuedP/E 36.4, Chemicals (Specialty) median 24.4, own median 17.9.Valuation 27
Its standout strengths are growth and fundamentals, while valuation holds the score back.
Daily figure as of 13 Nov 2026
How the score is calculatedScore overview
Score since yesterday from 69 to 68.
Fundamentals are strong, with stable profits and strong cash generation.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk medium
How well MEQIRI warnsIn the middle among smaller stocks.
From 2016 to 2025, 20 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.
What drives the risk
- cyclical sector (energy or materials), as a group, crashed more often in the backtest
- high growth grade (crashed more often in the backtest)
What lowers it
- solid fundamentals
Valuation
Valuation signal
Significantly overvaluedIn our model the price counts as cheap below $73.35 and expensive above $136.23 (uncertainty medium, based on the price swings of the past year).
The two parts of the fair value come to $89.86 (cash-flow model) and $100.87 (industry comparison), and the gap between them shows how uncertain the estimate is. The price is above both.
Calculated with a cost of equity of 8.8%. At 9.8% the fair value would be $87.61, at 7.8% it would be $107.01.
Valuation metrics
Half from the cash-flow model, half from earnings times the industry P/E (24.4).
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 27 Sep 2026, revenue rose 9% on the twelve months before. Revenue has grown solidly since 2007, at about 11% per year.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2026: gross 21%, operating 11%, net 8%.
Debt & balance sheet
latest quarterThe balance sheet is solid, with moderate debt and comfortable interest coverage.
Earnings
- Next earnings
- 27 Jan 2027in 75 days
- Last reported
- 26 Oct 2026EPS reported $1.34 (expected $1.19)above expectations
Analyst estimates
Earnings estimates have barely changed since 15 Oct 2026.
- Earnings per share
- $4.17+2.6%
- Revenue
- $1.19B+1.5%
- Earnings per share
- $4.74+0.8%
- Revenue
- $1.26B+0.6%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
Insiders
Open-market purchases and sales by executives, board members and major holders
2 insiders bought on the open market in the last 6 months, $261,576 in total.
Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.
What happened at Hawkins
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
461 rated companies in Basic Materials
- This company
- 68
- Sector median
- 57
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Chemicals (Specialty)
The next larger and next smaller companies by market value
- AshlandASH $3.45B53
- HEXPOLHPOL-B.ST $3.25B69
- Azelis GroupAZE.BR $3.24B60
- CalumetCLMT $3.21B47
- WD-40WDFC $2.95B73
- H.B. FullerFUL $2.66B53
- Quaker HoughtonKWR $2.64B53
- IngevityNGVT $2.09B60
ETFs that hold Hawkins
Held by 15 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| iShares Global Water UCITS ETFIQQQ | 0.52% | 0.65% | €1.96B |
| iShares S&P SmallCap 600 UCITS ETFIUS3 | 0.18% | 0.30% | €2.31B |
| Amundi MSCI Smart Cities UCITS ETF ACCAMEC | 0.14% | 0.45% | €62.23M |
Show 5 more
| State Street SPDR S&P U.S. Dividend Aristocrats UCITS ETF (Dist)SPYD | 0.13% | 0.35% | €3.66B |
| Xtrackers Russell 2000 UCITS ETF 1CXRS2 | 0.10% | 0.30% | €2.22B |
| State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc)ZPRR | 0.10% | 0.30% | €4.28B |
| L&G Russell 2000 US Small Cap Quality UCITS ETFETLZ | 0.10% | 0.30% | €185.82M |
| iShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETFSXRG | 0.07% | 0.43% | €2.5B |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2026, period end 29 Mar 2026
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 3 Jul 2026)
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.